We are CTA Digital Health US
The CTA Digital Health program enters its second iteration to enable Canada’s most promising early-stage digital health start-ups to secure market intelligence, strategic guidance and access to key stakeholders in the most dynamic innovation hubs in the US: Boston, New York, Philadelphia and San Francisco. The program is led by Canadian Consulates across the United States, and is delivered in step with industry-leading partners that are shaping the digital health landscape. The CTA Digital Health program began with a national recruitment effort designed to identify up-and-coming founders and technology from Canada’s diverse digital health ecosystem. Leading US venture capitalists and industry stakeholders evaluate the applicants based on their potential for growth in each market and select the top scoring companies to participate. The program will be delivered virtually and will provide customized virtual support from May to September 2021. There will be multiple opportunities for the cohort to connect with potential US investors, customers and strategic partners throughout the program including a 4-city taking place on September 7, 2021.
Ananda Devices’ technology enables 50x faster and 90x more cost-effective evaluation
of toxicity and efficacy of medications, cosmetics, and pesticides before contact with
humans. We help biopharmaceutical companies comply with legislation to reduce animal
experimentation and launch safer products to humans. Our products include organon-
a-chip devices to automate safety and efficacy analysis of compounds on models
of the human brain, spinal cord and innervated tissues. We also offer services to help
biopharmaceutical companies increase automation of specific assays such as developing
models of Parkinson-on-a-chip and Autism-on-a-chip.
Clinia’s intelligent health navigation tools allow organizations to streamline operational
workflows and improve overall user journeys. Our powerful infrastructure is built for health
and composed of a suite of entirely white-labeled solutions including a customizable
provider directory, AI-driven search engine and booking orchestrator. Using Clinia’s APIs
and SDKs, health organizations can build personalized navigation experiences within
their websites, portals or apps based on their own business rules.
We improve mental health and increase user engagement for digital and behavioral health
businesses through our digital music therapy service (Cloud API). Our music therapy
API delivers validated and personalized music therapy experiences based on data
collected from the patient, provider, or the digital platform. Traditional music therapists use
their senses to observe patients and their experiences to provide patient-specific help.
Our approach utilizes digital biomarkers, big data, and cutting-edge machine learning
techniques to turn music into personalized medicine.
Our product SieVRt is the world’s first virtual-reality platform for diagnostic radiology. The
platform digitizes the infrastructure of the radiology reading room and creates a virtual
twin of the radiologist’s workflow. With SieVRt and an all-in-one VR headset, a radiologist
has the freedom to work anywhere, anytime, at less than 20% of the normal cost. This
increases radiologist revenue while allowing them to provide more responsive and
collaborative care to patients.
MedMe’s web-based platform helps pharmacies schedule, document, and integrate
with health systems/devices to manage clinical services at scale. We facilitate robust
online scheduling, secure PHIPA/PIPEDA-compliant video consultations, documentation
and workflow, and automated follow-ups packaged in an integrated solution designed
specifically for the pharmacy workflow. Our modular architecture allows us to easily
customize instances based on the unique workflows and clinical service needs of each
pharmacy we serve.
The over prescribing of psychotropic drugs and restraints has become a global
healthcare concern because of its association with negative health outcomes including
adverse drug events, longer hospitalizations, increased resource allocation, and a greater
probability of readmissions and/or complications when returning home. Described by
nurses as “the digital crash cart for agitation”, MindfulGarden is positioned as the tool of
first reach for front line caregivers — a biofeedback platform that arrests, de-escalates,
and calms beginning with disruptive behaviors associated with delirium and dementia.
The most substantial problem in cancer care is that toxic treatments are administered
without knowing the benefits to individuals. We develop diagnostic tools that personalize
cancer treatments. Our proprietary machine learning algorithm is capable of scouring
large genomic databases to identify patterns in the molecular features of cancers that
predict survival. This has enabled us to rapidly develop nine tests for clinical decisionmaking,
including our lead product, Thyroid GuidePx – set to launch by the end of 2021.
ThyForLife enables >200M people globally to efficiently manage and optimize their
thyroid health. It’s the only mobile platform that streamlines all relevant data for thyroid
patients, enabling users to easily track, store, visualize and assess their condition in one
intuitive and streamlined location.
Key in-app product features include lab results and symptoms tracking, medication
management, visual data analysis, and (coming soon) a dedicated thyroid community,
and on-demand direct-to-patient telehealth services. ThyForLife addresses the major pain
points users encounter when managing their thyroid health, empowering them to lead
healthier and happier lives.